8-KLeadership ChangesExhibits & Filings

MCKESSON CORP 8-K Report, Executive Changes (Mar 19, 2019)

Filed March 19, 2019For Securities:MCK

Summary

McKesson Corporation (MCK) announced a significant leadership transition via an 8-K filing on March 19, 2019. Effective April 1, 2019, CEO and Chairman John H. Hammergren will transition to a Senior Advisor role. This move signals a planned succession and a shift in leadership responsibilities. As a Senior Advisor, Mr. Hammergren will receive a monthly consulting fee of $75,000, separate from his existing retirement benefits. This agreement is terminable by either party with six months' notice and will cease by the time McKesson no longer has the right to appoint directors to the board of Change Healthcare, LLC. Investors should monitor the company's strategic direction and leadership effectiveness under new management following this transition.

Key Highlights

  • 1John H. Hammergren, CEO and Chairman, will transition to a Senior Advisor role effective April 1, 2019.
  • 2The Senior Advisor Agreement includes a monthly consulting fee of $75,000.
  • 3Mr. Hammergren will not receive additional compensation beyond what is stipulated in his retirement agreement.
  • 4The agreement has a six-month termination notice period for either party.
  • 5The Senior Advisor role is tied to McKesson's board appointment rights at Change Healthcare, LLC, with the agreement terminating when those rights expire.
  • 6This filing primarily relates to a change in executive officer and related contractual arrangements.
  • 7The company has filed the Senior Advisor Agreement as an exhibit to this report.

Frequently Asked Questions

This 8-K filing primarily announces the transition of John H. Hammergren, the current CEO and Chairman, to a Senior Advisor role and outlines the terms of his agreement in that capacity.

Effective April 1, 2019, Mr. Hammergren will serve as a Senior Advisor. He will receive a monthly consulting fee of $75,000, in addition to benefits he is already entitled to under his retirement agreement.

The agreement is terminable by either McKesson or Mr. Hammergren with six months' notice. It also terminates automatically when McKesson loses its right to appoint directors to the board of Change Healthcare, LLC.

While this filing signals a leadership transition, it doesn't inherently indicate a strategic shift. The Senior Advisor role suggests a continued, albeit different, engagement from Mr. Hammergren, and the terms of his advisory role are linked to specific strategic assets like Change Healthcare, LLC.